Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Hina Zahid

Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email: [email protected]. Contact no. 011-43720751

Home

Hina Zahid

Articles By : Hina Zahid

Root canal treatment work still favored for badly damaged teeth

Written By Hina Zahid26 Nov 2021 9:00 AM IST

Few patients regret having a severely damaged tooth saved by a root canal filling. A University of Gothenburg thesis shows that 87 percent would...

Study reveals drinking coffee could lower risk of Alzheimer's disease

Written By Hina Zahid25 Nov 2021 10:00 AM IST

Good news for those of us who can't face the day without having coffee.A new study has revealed that drinking higher amounts of coffee may make you...

Doctors at Fortis Jaipur successfully remove a 20-year-old liver tumor, weighing 8.5 kilos from a 57-Year- Old-Female

Written By Hina Zahid25 Nov 2021 9:30 AM IST

Jaipur: Doctors at Fortis Escorts Hospital Jaipur successfully removed a 20-year-old tumor from the liver of a 54-year-old female patient. The tumor...

Dabigatran as good as Warfarin for prevention of cognitive decline in elderly with AF

Written By Hina Zahid25 Nov 2021 9:30 AM IST

DALLAS - The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with...

FDA approves first drug for post transplant resistant CMV infection

Written By Hina Zahid25 Nov 2021 9:15 AM IST

The U.S. Food and Drug Administration has approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12 years of...

Obesity raises risk of gum disease by inflating growth of bone-destroying cells: Study

Written By Hina Zahid25 Nov 2021 9:00 AM IST

BUFFALO, N.Y. - Chronic inflammation caused by obesity may trigger the development of cells that break down bone tissue, including the bone that holds...

Impaired Vision Increases Risk of Depression in Midlife Women

Written By Hina Zahid25 Nov 2021 9:00 AM IST

CLEVELAND, Ohio - Midlife women are known to have the highest prevalence of depression compared with all other age groups, and women have higher...

Only alcohol -- not caffeine, diet or lack of sleep -- might trigger atrial fibrillation

Written By Hina Zahid25 Nov 2021 9:00 AM IST

New research from UC San Francisco that tested possible triggers of a common heart condition, including caffeine, sleep deprivation and sleeping on...

$E-cigarette use linked to higher prevalence of fragility fractures$

E-cigarette use linked to higher prevalence of fragility fractures

Written By Hina Zahid25 Nov 2021 8:45 AM IST

Philadelphia - While conventional cigarette smoking is an established risk factor for osteoporosis and osteoporotic fracture, the effects of...

Breast MRI shows IUDs have systemic effects

Written By Hina Zahid24 Nov 2021 10:30 AM IST

CHICAGO - Intrauterine contraceptive devices (IUDs) appear to have systemic effects on the body like those of hormone replacement therapy, according...

Rajib Gandhi Government General Hospital Reduces wait Times with Web Portals

Closing in on a new test for Schistosomiasis

Written By Hina Zahid24 Nov 2021 9:15 AM IST

Researchers have made important progress towards a new diagnostic test for schistosomiasis, which could help the World Health Organisation (WHO)...

FDA Clears Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis

Written By Hina Zahid24 Nov 2021 9:00 AM IST

GALWAY, Ireland - The Food and Drug Administration (FDA) has cleared Neuromark Rhinitis Neurolysis Therapy which is first in-office treatment...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok